Propanc Biopharma, Inc. (PPCB) SEC Filings — 2024
20 SEC filings for Propanc Biopharma, Inc. (PPCB) in 2024.
Filings
- Propanc Biopharma Files 8-K: Agreements, Obligations, Equity Sales — 8-K · Dec 20, 2024
- Propanc Biopharma Enters Material Definitive Agreement — 8-K · Dec 6, 2024
- Propanc Biopharma Files Q1 2025 10-Q — 10-Q · Nov 14, 2024
- Propanc Biopharma Files S-1 with SEC — S-1 · Oct 30, 2024
- Propanc Biopharma Files 2024 10-K — 10-K · Sep 30, 2024
- Propanc Biopharma Enters Material Agreement, Sells Equity — 8-K · Sep 27, 2024
- Propanc Biopharma Enters Material Definitive Agreement — 8-K · Aug 30, 2024
- Propanc Biopharma Files 8-K: Material Agreement, Debt, Equity Sales — 8-K · Aug 15, 2024
- Propanc Biopharma Files 8-K on Agreements and Equity Sales — 8-K · Aug 7, 2024
- Propanc Biopharma Files 8-K on Agreements and Equity Sales — 8-K · Jul 2, 2024
- Propanc Biopharma Files 8-K: Material Agreement & Equity Sales — 8-K · Jun 21, 2024
- Propanc Biopharma Files 8-K/A Amendment — 8-K/A · Jun 13, 2024
- Propanc Biopharma Files 8-K on Agreements and Equity Sales — 8-K · Jun 12, 2024
- Propanc Biopharma Files 8-K: Material Agreement & Equity Sales — 8-K · Jun 5, 2024
- Propanc Biopharma Enters Material Definitive Agreement — 8-K · May 16, 2024
- Propanc Biopharma, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- Propanc Biopharma Files 8-K: Material Agreement & Equity Sales — 8-K · Apr 22, 2024
- Propanc Biopharma Files 8-K — 8-K · Apr 10, 2024
- Propanc Biopharma Files 8-K: Material Agreement, Debt, Equity Sales — 8-K · Mar 11, 2024
- Propanc Biopharma, Inc. Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 20, 2024